Rocket Pharmaceuticals Appoints Elisabeth Bj?rk, M.D., Ph.D. to Board of Directors
Rocket Pharmaceuticals, Inc. (RCKT)
Last rocket pharmaceuticals, inc. earnings: 3/5 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
rocketpharma.com
Company Research
Source: Business Wire
NEW YORK--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare disorders, today announces the appointment of Elisabeth Bj?rk, M.D., Ph.D. to its Board of Directors.“I am honored that Elisabeth will be joining Rocket’s Board of Directors,” said Gaurav Shah, M.D., Chief Executive Officer and President at Rocket. “Elisabeth’s appointment coincides with a period of accelerated clinical trial progress at Rocket. The depth of her experience in complex life-threatening disorders and her drug development expertise—from discovery through launch—comes at a perfect time in Rocket’s journey. We are particularly excited as her presence will augment our existing Board of Directors’ world-class research and financial expertise. Collectively, the management team could not hope for a better group of advisors and stewards for Rocket Pharma.”Dr. Bj?rk is the Senior Vice Preside
Show less
Read more
Impact Snapshot
Event Time:
RCKT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RCKT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RCKT alerts
High impacting Rocket Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
RCKT
News
- Rocket Pharmaceuticals (NASDAQ:RCKT) was given a new $5.00 price target on by analysts at Morgan Stanley.MarketBeat
- Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare ConferenceBusiness Wire
- Rocket Pharmaceuticals: Deep Dislocation Offers Asymmetric Upside On LAD-I Approval And Amended Danon Program [Seeking Alpha]Seeking Alpha
- Rocket Pharmaceuticals (NASDAQ:RCKT) was upgraded by analysts at TD Cowen to a "hold" rating.MarketBeat
- Rocket Pharmaceuticals Leads Our Trio Of Penny Stock Contenders [Yahoo! Finance]Yahoo! Finance
RCKT
Earnings
- 11/6/25 - Beat
RCKT
Sec Filings
- 1/6/26 - Form 4
- 11/20/25 - Form 4
- 11/20/25 - Form 4
- RCKT's page on the SEC website